These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 12963565)
1. Lipid-lowering drugs and the risk of depression and suicidal behavior. Yang CC; Jick SS; Jick H Arch Intern Med; 2003 Sep; 163(16):1926-32. PubMed ID: 12963565 [TBL] [Abstract][Full Text] [Related]
2. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study. Mullins CD; Rattinger GB; Kuznik A; Koren MJ Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915 [TBL] [Abstract][Full Text] [Related]
4. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis. Koro CE; Sowell MO; Stender M; Qizilbash N Clin Ther; 2008 Mar; 30(3):535-42. PubMed ID: 18405791 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. Koren MJ; Hunninghake DB; J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States. Foody JM; Joyce AT; Rudolph AE; Liu LZ; Benner JS Clin Ther; 2008 Jan; 30(1):195-205. PubMed ID: 18343257 [TBL] [Abstract][Full Text] [Related]
8. Statin but not non-statin lipid-lowering drugs decrease fracture risk: a nation-wide case-control study. Rejnmark L; Vestergaard P; Mosekilde L Calcif Tissue Int; 2006 Jul; 79(1):27-36. PubMed ID: 16868664 [TBL] [Abstract][Full Text] [Related]
9. Differences between statins on clinical endpoints: a population-based cohort study. Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665 [TBL] [Abstract][Full Text] [Related]
10. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. Strandberg TE; Feely J; Sigurdsson EL; Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694 [TBL] [Abstract][Full Text] [Related]
11. Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Jick SS; Choi H; Li L; McInnes IB; Sattar N Ann Rheum Dis; 2009 Apr; 68(4):546-51. PubMed ID: 18662929 [TBL] [Abstract][Full Text] [Related]
12. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658 [TBL] [Abstract][Full Text] [Related]
14. Chronic statin therapy and the risk of colorectal cancer. Yang YX; Hennessy S; Propert K; Hwang WT; Sarkar M; Lewis JD Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):869-76. PubMed ID: 18412290 [TBL] [Abstract][Full Text] [Related]
15. Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study. Sailler L; Pereira C; Bagheri A; Uro-Coste E; Roussel B; Adoue D; Fournie B; Laroche M; Zabraniecki L; Cintas P; Arlet P; Lapeyre-Mestre M; Montastruc JL Ann Rheum Dis; 2008 May; 67(5):614-9. PubMed ID: 17768174 [TBL] [Abstract][Full Text] [Related]
16. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin? Douketis JD; Melo M; Bell CM; Mamdani MM Am J Med; 2007 Apr; 120(4):369.e9-369.e14. PubMed ID: 17398234 [TBL] [Abstract][Full Text] [Related]
17. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study. Ye X; Gross CR; Schommer J; Cline R; St Peter WL Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593 [TBL] [Abstract][Full Text] [Related]
18. Statin use and risk of gastroduodenal ulcer and reflux esophagitis. Fujii T; Nakabayashi T; Hashimoto S; Kuwano H Hepatogastroenterology; 2009; 56(91-92):641-4. PubMed ID: 19621671 [TBL] [Abstract][Full Text] [Related]
19. Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study. Zhao SP; Peng DQ; Yu BL; Huo Y; Am Heart J; 2009 Oct; 158(4):509-512.e1. PubMed ID: 19781407 [TBL] [Abstract][Full Text] [Related]
20. The risk of cancer in users of statins. Graaf MR; Beiderbeck AB; Egberts AC; Richel DJ; Guchelaar HJ J Clin Oncol; 2004 Jun; 22(12):2388-94. PubMed ID: 15197200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]